← Leaderboards
Rafael A. Fridman
Wayne State University
$9,123,443
Attributed
$10,628,590
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,628,590 · 7
By mechanism
R01$10,244,110 · 5
R21$381,480 · 1
R13$3,000 · 1
Top collaborators
- Howard C Crawford4 shared
- Michael L Cher2 shared
- Jean-Philippe Francois Marie Coppe2 shared
Most similar at Wayne State University
Same institution · by research overlap
- Bonnie F Sloane$8,629,575
- Michael L Cher$3,816,963
- Elizabeth Berger$4,618,652
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellBaseTumor ProgressionIn VivoExtracellular MatrixMalignant NeoplasmsTumorTissuesIn VitroMatrix MetalloproteinasesMembraneProteolysisMolecularRegulationNeoplasm MetastasisHuman Mmp14 ProteinCollagenBiochemicalMediatingPlayNovel StrategiesCancer CellInvadedPeptide Hydrolases
Grant awards (35)
Collagen Signaling in Pancreatic Cancer$658,784
R01 · FY2025 · CA
Collagen Signaling in Pancreatic Cancer$630,684
R01 · FY2024 · CA
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia$167,592
R21 · FY2016 · CA · contact PI
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression$260,352
R01 · FY2015 · CA · contact PI
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia$213,888
R21 · FY2015 · CA · contact PI
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression$252,540
R01 · FY2014 · CA · contact PI
Targeting MT-MMPs in Cancer Progression$303,871
R01 · FY2013 · CA · contact PI
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression$244,731
R01 · FY2013 · CA · contact PI
Targeting MT-MMPs in Cancer Progression$325,782
R01 · FY2012 · CA · contact PI
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression$260,352
R01 · FY2012 · CA · contact PI
Targeting MT-MMPs in Cancer Progression$329,099
R01 · FY2011 · CA · contact PI
MT-MMP/DDR cross talk at the tumor cell-matrix interface and cancer progression$260,352
R01 · FY2011 · CA · contact PI
Gordon Research Conference and Gordon-Kenan Research Seminar on Matrix Metallopro$3,000
R13 · FY2011 · CA · contact PI
The MT1-MMP/RANKL/RANK Axis in Prostate Cancer Bone Metastasis$461,288
R01 · FY2010 · CA
Targeting MT-MMPs in Cancer Progression$349,585
R01 · FY2010 · CA · contact PI
Dynamic regulation of MT1-MMP at the tumor cell surface and malignancy$257,782
R01 · FY2010 · CA · contact PI
The MT1-MMP/RANKL/RANK Axis in Prostate Cancer Bone Metastasis$448,236
R01 · FY2009 · CA
Targeting MT-MMPs in Cancer Progression$366,136
R01 · FY2009 · CA · contact PI
Dynamic regulation of MT1-MMP at the tumor cell surface and malignancy$257,782
R01 · FY2009 · CA · contact PI
Dynamic regulation of MT1-MMP at the tumor cell surface and malignancy$280,357
R01 · FY2008 · CA · contact PI
Dynamic regulation of MT1-MMP at the tumor cell surface and malignancy$257,782
R01 · FY2007 · CA · contact PI
Novel approach for inhibition of MT1-MMP/gelatinase axis$342,824
R01 · FY2006 · CA · contact PI
Dynamic regulation of MT1-MMP at the tumor cell surface and malignancy$265,482
R01 · FY2006 · CA · contact PI
Novel approach for inhibition of MT1-MMP/gelatinase axis$351,075
R01 · FY2005 · CA
Novel approach for inhibition of MT1-MMP/gelatinase axis$351,075
R01 · FY2004 · CA
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION$265,995
R01 · FY2004 · CA
Novel approach for inhibition of MT1-MMP/gelatinase axis$351,075
R01 · FY2003 · CA
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS$271,848
R01 · FY2003 · CA
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION$265,995
R01 · FY2003 · CA
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION$265,995
R01 · FY2002 · CA
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS$263,931
R01 · FY2002 · CA
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION$279,995
R01 · FY2001 · CA
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS$256,246
R01 · FY2001 · CA
REGULATION OF MATRIX METALLOPROTEINASE ACTIVATION$258,298
R01 · FY2000 · CA
SURFACE BINDING AND ACTIVATION OF MMP9 IN TUMOR CELLS$248,781
R01 · FY2000 · CA